AB
ABTEC.OL
—
Oslo Børs
Personal Products
Aqua Bio Technology ASA
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
70,6M NOK
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
—
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
kr4,44
Open
—
Next earnings
2026-08-14
Ex-dividend
—
TR 1Y
—
About
Aqua Bio Technology ASA develops and commercializes biodegradable products for personal care and household use, leveraging patented technologies to create sustainable alternatives to conventional chemical-based products.
Business. Aqua Bio Technology ASA (ABTEC.OL) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in Norway, the company is primarily listed on the Oslo Børs.
Classification92 %
SectorConsumer Non-Cyclicals
Business sectorPersonal & Household Products & Services
IndustryPersonal Products
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability
—
not yet wired
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to ABTEC.OL. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsH1 2026 earnings (expected)2026-08-14 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Aqua Bio Technology ASA (ABTEC.OL) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in Norway, the company is primarily listed on the Oslo Børs.
Classification92 %
SectorConsumer Non-Cyclicals
Business sectorPersonal & Household Products & Services
IndustryPersonal Products
AI synthesis
GENERATED— missing data
Key takeaways
- Aqua Bio Technology ASA has a market capitalization of 77.14 million NOK with no dilution risk in the near term.
- The company's last actual EPS was 10.48 NOK, and revenue was 49.42 million NOK, but no industry benchmarks are available for comparison.
- Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
- The company does not disclose segment or geographic revenue breakdowns, limiting the ability to evaluate revenue concentration.
- Growth trajectory and forward-looking guidance are not available in the current dataset.
- No recent events or additional disclosures are available to assess strategic initiatives or operational developments.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Annual
ANNUALFiled 2017-02-16
FY 2017 · Full-year highlights
Revenue kr 106.6M, +478,9% YoY; Operating income −1 963,5% YoY.
Revenuekr 106.6M+478,9 % YoY
Operating income-kr 325.7M−1 963,5 % YoY
Net income-kr 337.4M−1 504,6 % YoY
Free cash flow-kr 326.7M−1 642,7 % YoY
EPS—
Operating cash flow-kr 46.9M−143,1 % YoY
Financials
Income statement
Revenuekr 106.6M
Gross profitkr 2.0M
Operating income-kr 325.7M
Net income-kr 337.4M
Margins
Gross margin1.9%
Operating margin-305.7%
Net margin-316.6%
FCF margin-306.6%
Balance sheet
Total assetskr 249.7M
Total liabilitieskr 331.4M
Total equity-kr 81.7M
Cash & equivalentskr 17.2M
Long-term debtkr 205.3M
Cash flow
Operating cash flow-kr 46.9M
CapEx-kr 1.1M
Free cash flow-kr 326.7M
SBC—
P&L flow · revenue → net income
Highlights
- ▍Revenue kr 106.6M, +478,9% YoY
- ▍Operating income −1 963,5% YoY
- ▍Net income −1 504,6% YoY
- ▍Free cash flow −1 642,7% YoY
- ▍Net margin -316.6%
ANNUALFiled 2016-02-10
FY 2016 · Full-year highlights
Revenue kr 18.4M, +162,3% YoY; Operating income +3,6% YoY.
Revenuekr 18.4M+162,3 % YoY
Operating income-kr 15.8M+3,6 % YoY
Net income-kr 21.0M−12,2 % YoY
Free cash flow-kr 18.7M−9,8 % YoY
EPS—
Operating cash flow-kr 19.3M−24,8 % YoY
Financials
Income statement
Revenuekr 18.4M
Gross profitkr 10.1M
Operating income-kr 15.8M
Net income-kr 21.0M
Margins
Gross margin54.7%
Operating margin-85.8%
Net margin-114.2%
FCF margin-101.8%
Balance sheet
Total assetskr 237.7M
Total liabilitieskr 152.0M
Total equitykr 85.8M
Cash & equivalentskr 4.8M
Long-term debtkr 52.7M
Cash flow
Operating cash flow-kr 19.3M
CapEx-kr 1.4M
Free cash flow-kr 18.7M
SBC—
P&L flow · revenue → net income
Highlights
- ▍Revenue kr 18.4M, +162,3% YoY
- ▍Operating income +3,6% YoY
- ▍Net income −12,2% YoY
- ▍Free cash flow −9,8% YoY
- ▍Net margin -114.2%
ANNUALFiled 2015-02-11
FY 2015 · Full-year highlights
Revenue kr 7.0M, +349,9% YoY; Operating income +8,3% YoY.
Revenuekr 7.0M+349,9 % YoY
Operating income-kr 16.4M+8,3 % YoY
Net income-kr 18.7M+2,0 % YoY
Free cash flow-kr 17.1M+22,0 % YoY
EPS—
Operating cash flow-kr 15.4M+26,3 % YoY
Financials
Income statement
Revenuekr 7.0M
Gross profitkr 2.3M
Operating income-kr 16.4M
Net income-kr 18.7M
Margins
Gross margin33.2%
Operating margin-233.3%
Net margin-267.0%
FCF margin-243.2%
Balance sheet
Total assetskr 67.2M
Total liabilitieskr 65.3M
Total equitykr 1.9M
Cash & equivalentskr 1.9M
Long-term debtkr 16.9M
Cash flow
Operating cash flow-kr 15.4M
CapExkr 0.00
Free cash flow-kr 17.1M
SBC—
P&L flow · revenue → net income
Highlights
- ▍Revenue kr 7.0M, +349,9% YoY
- ▍Operating income +8,3% YoY
- ▍Net income +2,0% YoY
- ▍Free cash flow +22,0% YoY
- ▍Net margin -267.0%
ANNUALFiled 2014-02-12
FY 2014 · Full-year highlights
Revenue kr 1.6M, +251,0% YoY; Operating income −10,9% YoY.
Revenuekr 1.6M+251,0 % YoY
Operating income-kr 17.9M−10,9 % YoY
Net income-kr 19.1M−30,0 % YoY
Free cash flow-kr 21.9M−48,6 % YoY
EPS—
Operating cash flow-kr 21.0M−57,2 % YoY
Financials
Income statement
Revenuekr 1.6M
Gross profitkr 607.9k
Operating income-kr 17.9M
Net income-kr 19.1M
Margins
Gross margin39.0%
Operating margin-1144.9%
Net margin-1225.4%
FCF margin-1403.5%
Balance sheet
Total assetskr 34.4M
Total liabilitieskr 15.7M
Total equitykr 18.7M
Cash & equivalentskr 13.4M
Long-term debtkr 7.1M
Cash flow
Operating cash flow-kr 21.0M
CapEx-kr 3.9M
Free cash flow-kr 21.9M
SBC—
P&L flow · revenue → net income
Highlights
- ▍Revenue kr 1.6M, +251,0% YoY
- ▍Operating income −10,9% YoY
- ▍Net income −30,0% YoY
- ▍Free cash flow −48,6% YoY
- ▍Net margin -1225.4%
ANNUALFiled 2013-02-13
FY 2013 · Full-year highlights
Revenue kr 444.4k; Operating income -kr 16.1M.
Revenuekr 444.4k
Operating income-kr 16.1M
Net income-kr 14.7M
Free cash flow-kr 14.7M
EPS—
Operating cash flow-kr 13.3M
Financials
Income statement
Revenuekr 444.4k
Gross profit-kr 537.1k
Operating income-kr 16.1M
Net income-kr 14.7M
Margins
Gross margin-120.9%
Operating margin-3624.1%
Net margin-3308.9%
FCF margin-3314.0%
Balance sheet
Total assetskr 16.2M
Total liabilitieskr 7.9M
Total equitykr 8.3M
Cash & equivalentskr 5.4M
Long-term debtkr 3.0M
Cash flow
Operating cash flow-kr 13.3M
CapEx-kr 135.7k
Free cash flow-kr 14.7M
SBC—
P&L flow · revenue → net income
Highlights
- ▍Revenue kr 444.4k
- ▍Operating income -kr 16.1M
- ▍Net margin -3308.9%
Valuation FY
Market price
kr4,52
Market cap
kr77.1M
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
—
Net cashⓘ
—
Current ratioⓘ
—
Debt / equityⓘ
—
ROAⓘ
—
ROEⓘ
—
Cash conversionⓘ
—
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
— missing data
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskUnknown
Benchmarks vs cohort
No cohort benchmark data available for this issuer yet.
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
Source documents
- Aqua Bio Technology ASA Market data — financials · 2026-05-27
- Aqua Bio Technology ASA Market data — analyst estimates · 2026-05-27
Ownership & reference
Leadership
- Kristian FlatenCEO
Insider activity
— missing data
Short positioning
— missing data
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
ABTEC.OLCanonical
Oslo Børs · NOK
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskUnknown
Evidence & claims
From filings & derived data- Net margin (FY 2024-12-31): -18,689.6%Derived (calculated)
- Debt-to-equity (FY 2024-12-31): 23.36xDerived (calculated)
- Return on assets (FY 2024-12-31): -155.7%Derived (calculated)
- Current ratio (FY 2024-12-31): 0.04xDerived (calculated)
- Return on equity (FY 2024-12-31): -3,793.4%Derived (calculated)
- Current liabilities (annual): NOK 85.5MBRREG filing
- Revenue (annual): NOK 1.25MBRREG filing
- Non current liabilities (annual): NOK 58.06MBRREG filing
- Pre-tax income (annual): NOK -233.29MBRREG filing
- Net income (annual): NOK -233.16MBRREG filing
- Operating income (annual): NOK -62.85MBRREG filing
- Total liabilities (annual): NOK 143.56MBRREG filing
- Non current assets (annual): NOK 146.02MBRREG filing
- Current assets (annual): NOK 3.69MBRREG filing
- Total assets (annual): NOK 149.71MBRREG filing
- Shareholders' equity (annual): NOK 6.15MBRREG filing
- Finance expense (annual): NOK 10.86MBRREG filing
- Total equity & liabilities (annual): NOK 149.71MBRREG filing
- Total operating expenses (annual): NOK 64.09MBRREG filing
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-08-14EVENTUpcomingH1 2026 earnings (expected) estimated date
2017-02-16 04:47 UTCEARNINGSQuarterly results — Q4 2016
2017-02-16 04:47 UTCEARNINGSAnnual results — FY 2017 Revenue NOK 106.6M · Net NOK -337.4M
2016-11-17 07:27 UTCEARNINGSQuarterly results — Q3 2016
2016-08-17 07:51 UTCEARNINGSQuarterly results — Q2 2016
2016-05-11 09:00 UTCEARNINGSQuarterly results — Q1 2016
2016-02-10 08:56 UTCEARNINGSQuarterly results — Q4 2015
2016-02-10 08:56 UTCEARNINGSAnnual results — FY 2016 Revenue NOK 18.4M · Net NOK -21.0M
2015-11-18 07:07 UTCEARNINGSQuarterly results — Q3 2015
2015-02-11 07:14 UTCEARNINGSAnnual results — FY 2015 Revenue NOK 7.0M · Net NOK -18.7M
2014-02-12 06:00 UTCEARNINGSAnnual results — FY 2014 Revenue NOK 1.6M · Net NOK -19.1M
2013-02-13 07:56 UTCEARNINGSAnnual results — FY 2013 Revenue NOK 0.4M · Net NOK -14.7M
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage